Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Indocyanine green-enhanced lymphography for upper extremity lymphedema: a novel severity staging system using dermal backflow patterns.

Identifieur interne : 002580 ( PubMed/Corpus ); précédent : 002579; suivant : 002581

Indocyanine green-enhanced lymphography for upper extremity lymphedema: a novel severity staging system using dermal backflow patterns.

Auteurs : Takumi Yamamoto ; Nana Yamamoto ; Kentaro Doi ; Azusa Oshima ; Hidehiko Yoshimatsu ; Takeshi Todokoro ; Fusa Ogata ; Makoto Mihara ; Mitsunaga Narushima ; Takuya Iida ; Isao Koshima

Source :

RBID : pubmed:21681123

English descriptors

Abstract

Management of arm lymphedema following breast cancer treatment is challenging, and emphasis should be put on early diagnosis and prevention of secondary lymphedema. Indocyanine green lymphography is becoming a method of choice for evaluation of lymphedema.

DOI: 10.1097/PRS.0b013e3182268cd9
PubMed: 21681123

Links to Exploration step

pubmed:21681123

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Indocyanine green-enhanced lymphography for upper extremity lymphedema: a novel severity staging system using dermal backflow patterns.</title>
<author>
<name sortKey="Yamamoto, Takumi" sort="Yamamoto, Takumi" uniqKey="Yamamoto T" first="Takumi" last="Yamamoto">Takumi Yamamoto</name>
<affiliation>
<nlm:affiliation>Department of Plastic and Reconstructive Surgery, Graduate School of Medicine, University of Tokyo, Tokyo, Japan. tyamamoto-tky@umin.ac.jp</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Yamamoto, Nana" sort="Yamamoto, Nana" uniqKey="Yamamoto N" first="Nana" last="Yamamoto">Nana Yamamoto</name>
</author>
<author>
<name sortKey="Doi, Kentaro" sort="Doi, Kentaro" uniqKey="Doi K" first="Kentaro" last="Doi">Kentaro Doi</name>
</author>
<author>
<name sortKey="Oshima, Azusa" sort="Oshima, Azusa" uniqKey="Oshima A" first="Azusa" last="Oshima">Azusa Oshima</name>
</author>
<author>
<name sortKey="Yoshimatsu, Hidehiko" sort="Yoshimatsu, Hidehiko" uniqKey="Yoshimatsu H" first="Hidehiko" last="Yoshimatsu">Hidehiko Yoshimatsu</name>
</author>
<author>
<name sortKey="Todokoro, Takeshi" sort="Todokoro, Takeshi" uniqKey="Todokoro T" first="Takeshi" last="Todokoro">Takeshi Todokoro</name>
</author>
<author>
<name sortKey="Ogata, Fusa" sort="Ogata, Fusa" uniqKey="Ogata F" first="Fusa" last="Ogata">Fusa Ogata</name>
</author>
<author>
<name sortKey="Mihara, Makoto" sort="Mihara, Makoto" uniqKey="Mihara M" first="Makoto" last="Mihara">Makoto Mihara</name>
</author>
<author>
<name sortKey="Narushima, Mitsunaga" sort="Narushima, Mitsunaga" uniqKey="Narushima M" first="Mitsunaga" last="Narushima">Mitsunaga Narushima</name>
</author>
<author>
<name sortKey="Iida, Takuya" sort="Iida, Takuya" uniqKey="Iida T" first="Takuya" last="Iida">Takuya Iida</name>
</author>
<author>
<name sortKey="Koshima, Isao" sort="Koshima, Isao" uniqKey="Koshima I" first="Isao" last="Koshima">Isao Koshima</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2011">2011</date>
<idno type="RBID">pubmed:21681123</idno>
<idno type="pmid">21681123</idno>
<idno type="doi">10.1097/PRS.0b013e3182268cd9</idno>
<idno type="wicri:Area/PubMed/Corpus">002580</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002580</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Indocyanine green-enhanced lymphography for upper extremity lymphedema: a novel severity staging system using dermal backflow patterns.</title>
<author>
<name sortKey="Yamamoto, Takumi" sort="Yamamoto, Takumi" uniqKey="Yamamoto T" first="Takumi" last="Yamamoto">Takumi Yamamoto</name>
<affiliation>
<nlm:affiliation>Department of Plastic and Reconstructive Surgery, Graduate School of Medicine, University of Tokyo, Tokyo, Japan. tyamamoto-tky@umin.ac.jp</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Yamamoto, Nana" sort="Yamamoto, Nana" uniqKey="Yamamoto N" first="Nana" last="Yamamoto">Nana Yamamoto</name>
</author>
<author>
<name sortKey="Doi, Kentaro" sort="Doi, Kentaro" uniqKey="Doi K" first="Kentaro" last="Doi">Kentaro Doi</name>
</author>
<author>
<name sortKey="Oshima, Azusa" sort="Oshima, Azusa" uniqKey="Oshima A" first="Azusa" last="Oshima">Azusa Oshima</name>
</author>
<author>
<name sortKey="Yoshimatsu, Hidehiko" sort="Yoshimatsu, Hidehiko" uniqKey="Yoshimatsu H" first="Hidehiko" last="Yoshimatsu">Hidehiko Yoshimatsu</name>
</author>
<author>
<name sortKey="Todokoro, Takeshi" sort="Todokoro, Takeshi" uniqKey="Todokoro T" first="Takeshi" last="Todokoro">Takeshi Todokoro</name>
</author>
<author>
<name sortKey="Ogata, Fusa" sort="Ogata, Fusa" uniqKey="Ogata F" first="Fusa" last="Ogata">Fusa Ogata</name>
</author>
<author>
<name sortKey="Mihara, Makoto" sort="Mihara, Makoto" uniqKey="Mihara M" first="Makoto" last="Mihara">Makoto Mihara</name>
</author>
<author>
<name sortKey="Narushima, Mitsunaga" sort="Narushima, Mitsunaga" uniqKey="Narushima M" first="Mitsunaga" last="Narushima">Mitsunaga Narushima</name>
</author>
<author>
<name sortKey="Iida, Takuya" sort="Iida, Takuya" uniqKey="Iida T" first="Takuya" last="Iida">Takuya Iida</name>
</author>
<author>
<name sortKey="Koshima, Isao" sort="Koshima, Isao" uniqKey="Koshima I" first="Isao" last="Koshima">Isao Koshima</name>
</author>
</analytic>
<series>
<title level="j">Plastic and reconstructive surgery</title>
<idno type="eISSN">1529-4242</idno>
<imprint>
<date when="2011" type="published">2011</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Breast Neoplasms (pathology)</term>
<term>Breast Neoplasms (surgery)</term>
<term>Cohort Studies</term>
<term>Coloring Agents</term>
<term>Early Diagnosis</term>
<term>Female</term>
<term>Humans</term>
<term>Indocyanine Green</term>
<term>Lymphedema (diagnostic imaging)</term>
<term>Lymphedema (etiology)</term>
<term>Lymphedema (physiopathology)</term>
<term>Lymphography (methods)</term>
<term>Mastectomy (adverse effects)</term>
<term>Mastectomy (methods)</term>
<term>Middle Aged</term>
<term>Neoplasm Staging</term>
<term>Postoperative Complications (diagnostic imaging)</term>
<term>Retrospective Studies</term>
<term>Sensitivity and Specificity</term>
<term>Severity of Illness Index</term>
<term>Upper Extremity</term>
</keywords>
<keywords scheme="MESH" type="chemical" xml:lang="en">
<term>Coloring Agents</term>
<term>Indocyanine Green</term>
</keywords>
<keywords scheme="MESH" qualifier="adverse effects" xml:lang="en">
<term>Mastectomy</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic imaging" xml:lang="en">
<term>Lymphedema</term>
<term>Postoperative Complications</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en">
<term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en">
<term>Lymphography</term>
<term>Mastectomy</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en">
<term>Breast Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en">
<term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="surgery" xml:lang="en">
<term>Breast Neoplasms</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Cohort Studies</term>
<term>Early Diagnosis</term>
<term>Female</term>
<term>Humans</term>
<term>Middle Aged</term>
<term>Neoplasm Staging</term>
<term>Retrospective Studies</term>
<term>Sensitivity and Specificity</term>
<term>Severity of Illness Index</term>
<term>Upper Extremity</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Management of arm lymphedema following breast cancer treatment is challenging, and emphasis should be put on early diagnosis and prevention of secondary lymphedema. Indocyanine green lymphography is becoming a method of choice for evaluation of lymphedema.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">21681123</PMID>
<DateCreated>
<Year>2011</Year>
<Month>09</Month>
<Day>16</Day>
</DateCreated>
<DateCompleted>
<Year>2011</Year>
<Month>11</Month>
<Day>09</Day>
</DateCompleted>
<DateRevised>
<Year>2016</Year>
<Month>11</Month>
<Day>25</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1529-4242</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>128</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2011</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Plastic and reconstructive surgery</Title>
<ISOAbbreviation>Plast. Reconstr. Surg.</ISOAbbreviation>
</Journal>
<ArticleTitle>Indocyanine green-enhanced lymphography for upper extremity lymphedema: a novel severity staging system using dermal backflow patterns.</ArticleTitle>
<Pagination>
<MedlinePgn>941-7</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1097/PRS.0b013e3182268cd9</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Management of arm lymphedema following breast cancer treatment is challenging, and emphasis should be put on early diagnosis and prevention of secondary lymphedema. Indocyanine green lymphography is becoming a method of choice for evaluation of lymphedema.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Twenty patients with secondary arm lymphedema after breast cancer treatment underwent indocyanine green lymphography. Characteristic findings of indocyanine green lymphography were analyzed according to corresponding clinical stages and duration of edema. Based on changes in indocyanine green lymphography findings with progression of lymphedema, a new severity stage, arm dermal backflow stage, was developed and compared with clinical stages.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">The indocyanine green lymphographic findings were classified into two large groups: linear pattern and dermal backflow patterns. The dermal backflow pattern could be subdivided into splash, stardust, and diffuse patterns. The dermal backflow patterns were found more frequently than the linear pattern in the proximal upper extremity (p=0.001). The dermal backflow patterns also increased significantly in prevalence overall as the duration of lymphedema increased (p=0.032). The arm dermal backflow stage was linearly correlated with clinical stage as described by the line y=1.092x+0.083 (R=0.997; analysis of variance, p<0.001).</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Indocyanine green lymphography is a safe and convenient evaluation method for lymphedema that allows qualitative pathophysiologic assessment of lymphedema. The arm dermal backflow stage, based on indocyanine green lymphographic findings, is a simple severity staging system that demonstrates a significant correlation with clinical stage. Indocyanine green lymphography may come to play an important role in early diagnosis of secondary arm lymphedema.</AbstractText>
<AbstractText Label="CLINICAL QUESTION/LEVEL OF EVIDENCE" NlmCategory="METHODS">Diagnostic, V.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Yamamoto</LastName>
<ForeName>Takumi</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Department of Plastic and Reconstructive Surgery, Graduate School of Medicine, University of Tokyo, Tokyo, Japan. tyamamoto-tky@umin.ac.jp</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Yamamoto</LastName>
<ForeName>Nana</ForeName>
<Initials>N</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Doi</LastName>
<ForeName>Kentaro</ForeName>
<Initials>K</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Oshima</LastName>
<ForeName>Azusa</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Yoshimatsu</LastName>
<ForeName>Hidehiko</ForeName>
<Initials>H</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Todokoro</LastName>
<ForeName>Takeshi</ForeName>
<Initials>T</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Ogata</LastName>
<ForeName>Fusa</ForeName>
<Initials>F</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Mihara</LastName>
<ForeName>Makoto</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Narushima</LastName>
<ForeName>Mitsunaga</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Iida</LastName>
<ForeName>Takuya</ForeName>
<Initials>T</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Koshima</LastName>
<ForeName>Isao</ForeName>
<Initials>I</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Plast Reconstr Surg</MedlineTA>
<NlmUniqueID>1306050</NlmUniqueID>
<ISSNLinking>0032-1052</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D004396">Coloring Agents</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>IX6J1063HV</RegistryNumber>
<NameOfSubstance UI="D007208">Indocyanine Green</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
<QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D004396" MajorTopicYN="N">Coloring Agents</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D042241" MajorTopicYN="N">Early Diagnosis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007208" MajorTopicYN="Y">Indocyanine Green</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008209" MajorTopicYN="N">Lymphedema</DescriptorName>
<QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName>
<QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
<QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008220" MajorTopicYN="N">Lymphography</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008408" MajorTopicYN="N">Mastectomy</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName>
<QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009367" MajorTopicYN="N">Neoplasm Staging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName>
<QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D034941" MajorTopicYN="N">Upper Extremity</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="entrez">
<Year>2011</Year>
<Month>6</Month>
<Day>18</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2011</Year>
<Month>6</Month>
<Day>18</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2011</Year>
<Month>11</Month>
<Day>10</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">21681123</ArticleId>
<ArticleId IdType="doi">10.1097/PRS.0b013e3182268cd9</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002580 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 002580 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:21681123
   |texte=   Indocyanine green-enhanced lymphography for upper extremity lymphedema: a novel severity staging system using dermal backflow patterns.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i   -Sk "pubmed:21681123" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1 

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024